Elon Musk’s Neuralink Gets FDA Approval for Brain Implant Study

The first-ever human trial of Neuralink's brain implant is now on its way.

Elon Musk's Neuralink, a brain-implant firm, received approval from the FDA to conduct its first-ever in-human clinical study.

The US Food and Drug Administration (FDA) approval gives Neuralink's device implant test on humans a go signal.

Elon Musk's Neuralink FDA Approval for Brain Implant Study

Elon Musk
SAN FRANCISCO, CALIFORNIA - JANUARY 24: Tesla CEO Elon Musk leaves the Phillip Burton Federal Building on January 24, 2023 in San Francisco, California. Justin Sullivan/Getty Images

According to CNBC, the Musk-owned firm Neuralink announced that the FDA has already approved its study of brain implants in humans.

The brain implant device, Link, is surgically implanted into the brain. It contains a grid of electrodes that can record electrical activity from the brain. The electrodes then connect to a computer, which can translate the electrical signals into commands, which control devices or even thoughts.

The Musk-led company took to Twitter to confirm the recent FDA approval. It says, "This is the result of incredible work by the Neuralink team in close collaboration with the FDA." On top of that, Neuralink notes that it "represents an important first step that will one day allow our technology to help many people."

The FDA approval for the clinical study is a major milestone for Neuralink, one of the well-known firms in the burgeoning brain-computer interface (BCI) industry. The company is widely known due to the popularity of its owner, no less than the Tesla, SpaceX, and Twitter CEO, Musk.

What Does Neuralink Do?

Elon Musk
Tesla CEO Elon Musk smiles as he addresses guests at the Offshore Northern Seas 2022 (ONS) meeting in Stavanger, Norway on August 29, 2022. - The meeting, held in Stavanger from August 29 to September 1, 2022, presents the latest developments in Norway and internationally related to the energy, oil and gas sector. CARINA JOHANSEN/NTB/AFP via Getty Images

Musk believes that Neuralink's technology has the potential to revolutionize the way we interact with the world. The billionaire entrepreneur envisions a future where people with disabilities can use BCIs to regain mobility and independence.

The Neuralink owner also believes that brain implants could treat neurological disorders, such as Alzheimer's disease and Parkinson's disease. Not to mention that Musk seeks to cure other conditions, including obesity and depression, with the help of his brain implant firm.

Besides addressing pesky diseases, the ultra-billionaire also touts that brain implants deliver groundbreaking advancements, such as browsing the web and telepathy.

Musk is pretty confident with the brain implant tech. Last year, the Tesla and SpaceX big boss said he is willing to impact the device to his children, as he touted its safety.

Neuralink Human Trials

As per Reuters, Musk has been floating the idea of starting Nueralink's human trials as early as 2019. But it never actually materialized during that year.

As it turns out, Neuralink only requested FDA's approval last 2022, according to the tech firm's employees who spoke to Reuters. And last March, the regulator reportedly rejected its application, citing safety issues with the implant wires and lithium battery.

Last November, the tech entrepreneur teased that Neuralink is already six months away from beginning its first-ever human trial, according to The Verge.

And this time, the Musk-owned brain implant firm, Neuralink, has gotten FDA's nod to kick off its human trials.

Tags
FDA, Elon Musk
Real Time Analytics